Effect of Very Low Carbohydrate Diet on Glycemic, Metabolic, Glycated and Inflammatory Markers in Gestational Diabetes Mellitus

Sponsor
Khyber Medical University Peshawar (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05305352
Collaborator
(none)
100
1
2
3
33.1

Study Details

Study Description

Brief Summary

Uncontrolled Gestational Diabetes Mellitus may leads to maternal and fetal complications. These complications can be avoided by adopting the dietary modifications along with medications. Previous studies suggested that consumption of low Carbohydrate diet improves Gestational Diabetes and related complications. Therefore, this study aims to investigate the effect of very low carbohydrate dietary intervention on glycemic, glycemic, metabolic, glycated and inflammatory markers.

Condition or Disease Intervention/Treatment Phase
  • Other: Very low carbohydrate dietary intervention
N/A

Detailed Description

This will be randomized controlled trial of 80-100 Gestational diabetic women of second trimester to investigate the effect of very low carbohydrate dietary intervention on glycemic, metabolic, glycated and inflammatory markers.

Subjects will be recruited from ob/gyn outpatient of different hospitals. Eligible subjects will be enrolled in the study and will be allocated into two groups. One will be intervention and other will be control group. At baseline fasting blood samples from both group will be taken and will be analyzed for different biomarkers. Thereafter, the experimental group will be counseled about their modified diet (very low carbohydrate diet <10%,40-50% protein and lipid in diet). Control group will be allowed to continue their routine diet counselled as part of their antenatal care.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Very Low Carbohydrate Dietary Intervention in Gestational Diabetes Mellitus: Effect on Glycemic, Metabolic, Glycated and Inflammatory Marker: A Randomized Controlled Trial
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: No intervention

The no intervention arm will not receive counselling but will follow their routine diet suggested during their routine antenatal visits.

Experimental: Intervention

The intervention arm will be counselled about very low carbohydrate diet (<10%carbohydrate)

Other: Very low carbohydrate dietary intervention
The experimental group will be counseled about very low carbohydrate diet i.e., <10% carbohydrate,40-50% protein and lipid in diet).

Outcome Measures

Primary Outcome Measures

  1. Asses change in Fasting blood glucose [Baseline after one month and two month]

  2. Asses change in Postprandial glucose [Baseline after one month and two month]

  3. Asses change in Glycated hemoglobin A1c (HbA1c) [Baseline after one month and two month]

  4. Asses change in Lean and fat body mass [Baseline after one month and two month]

  5. Asses change in Fasting insulin [Baseline after one month and two month]

  6. Asses change in HOMA-IR [Baseline after one month and two month]

  7. Asses change in Adiponectin [Baseline after one month and two month]

  8. Carboxymethyl-lysine [Baseline after one month and two month]

  9. Asses change in C-reactive protein [Baseline after one month and two month]

  10. Asses change in NFk [Baseline after one month and two month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 2nd trimester women with GDM

  • Either taking or not taking oral hypoglycemic agent or insulin

Exclusion Criteria:
  • Previously known type 1 or type 2 Diabetic patients

  • Age less than 18 and above 40 years

  • Any other chronic disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Khyber Medical University Peshawar KPK Pakistan 25100

Sponsors and Collaborators

  • Khyber Medical University Peshawar

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Bibi Hajira, Assistant Professor, Khyber Medical University Peshawar
ClinicalTrials.gov Identifier:
NCT05305352
Other Study ID Numbers:
  • DIR/KMU-AS&RB/EV/001551
First Posted:
Mar 31, 2022
Last Update Posted:
Apr 5, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bibi Hajira, Assistant Professor, Khyber Medical University Peshawar
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 5, 2022